Strong Vivian E, Devaud Nicolas, Allen Peter J, Gonen Mithat, Brennan Murray F, Coit Daniel
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2009 Jun;16(6):1507-13. doi: 10.1245/s10434-009-0386-8. Epub 2009 Apr 4.
The aim of this study is to compare technical feasibility and oncologic efficacy of totally laparoscopic versus open subtotal gastrectomy for gastric adenocarcinoma.
Laparoscopic gastrectomy for adenocarcinoma is emerging in the West as a technique that may offer benefits for patients, although large-scale studies are lacking.
This study was designed as a case-controlled study from a prospective gastric cancer database. Thirty consecutive patients undergoing laparoscopic subtotal gastrectomy for adenocarcinoma were compared with 30 patients undergoing open subtotal gastrectomy. Controls were matched for stage, age, and gender via a statistically generated selection of all gastrectomies performed during the same period of time. Patient demographics, tumor-node-metastasis (TNM) stage, histologic features, location of tumor, lymph node retrieval, recurrence, margins, and early and late postoperative complications were compared.
Tumor location and histology were similar between the two groups. Median operative time for the laparoscopic approach was 270 min (range 150-485 min) compared with median of 126 min (range 85-205 min) in the open group (p < 0.01). Hospital length of stay after laparoscopic gastrectomy was 5 days (range 2-26 days), compared with 7 days (range 5-30 days) in the open group (p = 0.01). Postoperative pain, as measured by number of days of IV narcotic use, was significantly lower for laparoscopic patients, with a median of 3 days (range 0-11 days) compared with 4 days (range 1-13 days) in the open group (p < 0.01). Postoperative early complications trended towards a decrease for laparoscopic versus open surgery patients (p = 0.07); however, there were significantly more late complications for the open group (p = 0.03). Short-term recurrence-free survival and margin status was similar between the two groups (p = not significant) with adequate lymph node retrieval in both groups.
Laparoscopic subtotal gastrectomy for adenocarcinoma is comparable to the open approach with regard to oncologic principles of resection, with equivalent margin status and adequate lymph node retrieval, demonstrating technically feasibility and equivalent short-term recurrence-free survival. Additional benefits of decreased postoperative complications, decreased length of hospital stay, and decreased narcotic use make this a preferable approach for selected patients.
本研究旨在比较完全腹腔镜下与开放胃次全切除术治疗胃腺癌的技术可行性及肿瘤学疗效。
在西方,腹腔镜下胃腺癌切除术作为一种可能给患者带来益处的技术正在兴起,尽管缺乏大规模研究。
本研究设计为一项基于前瞻性胃癌数据库的病例对照研究。将连续30例行腹腔镜下胃次全切除术治疗腺癌的患者与30例行开放胃次全切除术的患者进行比较。通过对同一时期所有胃切除术进行统计学筛选,使对照组在分期、年龄和性别方面相匹配。比较患者的人口统计学特征、肿瘤-淋巴结-转移(TNM)分期、组织学特征、肿瘤位置、淋巴结清扫情况、复发情况、切缘情况以及术后早期和晚期并发症。
两组的肿瘤位置和组织学情况相似。腹腔镜手术组的中位手术时间为270分钟(范围150 - 485分钟),而开放手术组为126分钟(范围85 - 205分钟)(p < 0.01)。腹腔镜胃切除术后的住院时间为5天(范围2 - 26天),开放手术组为7天(范围5 - 30天)(p = 0.01)。以静脉使用麻醉药的天数衡量,腹腔镜手术患者的术后疼痛明显更低,中位天数为3天(范围0 - 11天),开放手术组为4天(范围1 - 13天)(p < 0.01)。腹腔镜手术患者与开放手术患者相比,术后早期并发症有减少趋势(p = 0.07);然而,开放手术组的晚期并发症明显更多(p = 0.03)。两组的短期无复发生存率和切缘情况相似(p = 无显著性差异),两组均有足够的淋巴结清扫。
就切除的肿瘤学原则而言,腹腔镜下胃次全切除术治疗腺癌与开放手术相当,切缘情况相同且有足够的淋巴结清扫,证明了技术可行性和相当的短期无复发生存率。术后并发症减少、住院时间缩短和麻醉药使用减少等额外益处使该方法成为部分患者的优选术式。